论文部分内容阅读
目的 :比较钬激光前列腺切除术 (HoLRP)和经尿道前列腺汽化电切术 (TUEVP)对有症状前列腺增生症(BPH)的治疗效果。方法 :分别采用HoLRP和TUEVP对 2 4 8例BPH进行治疗。结果 :两组手术前后国际前列腺症状评分 (IPSS)、生活质量评分 (QOL)、最大尿流率 (Qmax)、剩余尿 (RUV)比较均得到显著改善 (P <0 .0 0 1 ) ;两组比较无显著性差异 (P >0 .0 5)。HoLRP组手术时间较TUEVP组长 (P <0 .0 0 1 ) ,术中出血HoL RP组较TUEVP组少 (P <0 .0 0 1 ) ,术后留置尿管时间、术后住院时间及术后并发症HoLRP组较TUEVP组明显减少 (P <0 .0 0 1 )。术后阳痿发生率 :HoLRP组为 1 .2 % ,TUEVP组为 7.7% (P <0 .0 5)。结论 :HoLRP能达到与TUEVP完全相同的治疗效果 ,且并发症少 ,近期疗效满意。是目前BPH激光治疗中较有发展前途的一种新技术
Objective: To compare the therapeutic effects of holmium laser prostatectomy (HoLRP) and transurethral vaporization of the prostate (TUEVP) on symptomatic benign prostatic hyperplasia (BPH). Methods: Two hundred and eighty-eight cases of BPH were treated with HoLRP and TUEVP respectively. Results: The scores of International Prostate Symptom Score (IPSS), Quality of Life Scale (QOL), Qmax and Residual Urine (RUV) in both groups were significantly improved before and after operation (P <0. 001) There was no significant difference between the two groups (P> 0.05). The operative time of the HoLRP group was shorter than that of the TUEVP group (P <0.01), but less in the HoL RP group than in the TUEVP group (P <0.01), postoperative catheterization time, postoperative hospital stay Postoperative complications in the HoLRP group were significantly lower than those in the TUEVP group (P <0.01). Postoperative impotence incidence: HoLRP group was 1.2%, TUEVP group was 7.7% (P <0.05). Conclusion: HoLRP can achieve exactly the same therapeutic effect as TUEVP with less complications and satisfactory short-term curative effect. Is a new technology in the current BPH laser treatment more promising